ArticleEuropean journal of clinical pharmacology2017

Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis.

Angela W Dymond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.